XML 81 R71.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-based Compensation and Benefits - Summary of Restricted Stock Activity (Details)
9 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Restricted stock shares  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Unvested Restricted shares, Beginning (in shares) | shares 292,014
Unvested Restricted shares, Granted (in shares) | shares 169,687
Unvested Restricted shares, Vested (in shares) | shares (103,216)
Unvested Restricted shares, Forfeited (in shares) | shares (26,535)
Unvested Restricted shares, Ending (in shares) | shares 331,950
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted average grant-date fair value, Beginning (in dollars per share) $ 34.43
Weighted average grant-date fair value, Granted (in dollars per share) 38.07
Weighted average grant-date fair value, Vested (in dollars per share) 35.69
Weighted average grant-date fair value, Forfeited (in dollars per share) 35.8
Weighted average grant-date fair value, Ending (in dollars per share) $ 35.79
Performance stock units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Unvested Restricted shares, Beginning (in shares) | shares 198,264
Unvested Restricted shares, Granted (in shares) | shares 74,628
Unvested Restricted shares, Net adjustment due to performance (in shares) | shares 3,723
Unvested Restricted shares, Vested (in shares) | shares (51,658)
Unvested Restricted shares, Forfeited (in shares) | shares (8,712)
Unvested Restricted shares, Ending (in shares) | shares 216,245
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted average grant-date fair value, Beginning (in dollars per share) $ 34.31
Weighted average grant-date fair value, Granted (in dollars per share) 36.1
Weighted average grant-date fair value, Net adjustment due to performance (in dollars per share) 55.54
Weighted average grant-date fair value, Vested (in dollars per share) 39.63
Weighted average grant-date fair value, Forfeited (in dollars per share) 33.41
Weighted average grant-date fair value, Ending (in dollars per share) 34.06
EPS  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted average grant-date fair value, Granted (in dollars per share) 38.44
ROTA  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted average grant-date fair value, Granted (in dollars per share) 38.44
TSR  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted average grant-date fair value, Granted (in dollars per share) $ 32.19
Weighted average beginning measurement period price | $ $ 45.14